Author： Glassman A.H.
Publisher： Elsevier
ISSN： 0924-977X
Source： European Neuropsychopharmacology, Vol.5, Iss.3, 1995-09, pp. : 172-172
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Amiodarone − increased risk of mortality?
Reactions Weekly, Vol. 1, Iss. 1191, 2008-01 ,pp. :
Access to resources
Recommend
No increase in HF risk or mortality with thiazolidinediones
Reactions Weekly, Vol. 1, Iss. 1160, 2007-01 ,pp. :
Risk of depression increased 50% in diabetes
Reactions Weekly, Vol. 1, Iss. 1386, 2012-01 ,pp. :
Mefloquine not associated with increased risk of depression
Inpharma, Vol. 1, Iss. 1425, 2004-01 ,pp. :
Mortality, CHF risk increases with rosiglitazone use
Reactions Weekly, Vol. 1, Iss. 1231, 2008-01 ,pp. :